Covaxin gets emergency use approval in kids between 2-18 age group

0
28

October 12

Bharat Biotech’s Covaxin has got the emergency use approval for children in the age group of 2 to 18 years from the Drugs Controller General of India (DCGA).

Bharat Biotech had earlier submitted the Phase II & III trail data of Covaxin on Children to DCGI.

The Subject Expert Committee on Covid-19 gave the approval for the emergency use in the children.

The vaccine will be administered in two doses with 20 days of interval.

The expert panel said in a statement, “After detailed deliberation, the committee recommended for grant of market authorisation of the vaccine for the age group of 2 to 18 years for restricted use in emergency situation.”

Bharat Biotech needs to submit safety data with due analysis every 15 days for the first two months and monthly thereafter.

LEAVE A REPLY

Please enter your comment!
Please enter your name here